Papular urticaria - 丘疹性蕁麻疹
relevance score : -100.0%
ReferencesUrticaria 通常會出現劇烈搔癢的凸起傷痕，有時伴隨皮下組織腫脹。治療主要包括避免已知的觸發因素。第一線藥物包括新型抗組織胺藥，必要時可調整至較高劑量。其他藥物如較舊的抗組織胺、H2 阻斷劑、白三烯受體拮抗劑、更強的抗組織胺以及短期使用的皮質類固醇，可作為額外輔助。如果儘管採取上述措施，蕁麻疹仍持續，患者可能需要轉介給專科醫師，考慮使用 omalizumab 或 cyclosporine 等進一步治療。
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.
本篇綜述概述了治療蕁麻疹的最新指南，並提供了對其病因的新認識。
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.
Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids
○ 治療 - 非處方藥
#OTC antihistamine